SCHEMBL3960993

SCHEMBL3960993

Fc1cc(N2CCN(CCC3CNc4ccccc43)CC2)cc2cc[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
DRD4 P21917 6/20 0.37
HTR7 P34969 8/20 0.37
DRD2 P14416 6/20 0.37
DRD3 P35462 4/20 0.37
DRD1 P21728 3/20 0.34
HTR2A P28223 3/20 0.34
ADRA1A P35348 3/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1B P35368 1/20 0.34
HTR2B P41595 1/20 0.34
HTR2C P28335 2/20 0.34
HTR6 P50406 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3960852 1.00 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3DRD4HTR7
SCHEMBL3958641 0.83 HTR7 (0.49) SLC6A2SLC6A4SLC6A3DRD4HTR7
SCHEMBL3957776 0.83 HTR7 (0.49) SLC6A2SLC6A4SLC6A3DRD4HTR7
SCHEMBL3957782 0.83 HTR7 (0.49) SLC6A2SLC6A4SLC6A3DRD4HTR7
SCHEMBL11882731 0.78 DRD3 (0.52) DRD4HTR7DRD2DRD3HTR1A
SCHEMBL3953411 0.76 KDM4E (0.38) SLC6A2SLC6A4SLC6A3DRD4HTR7
SCHEMBL3953405 0.76 KDM4E (0.38) SLC6A2SLC6A4SLC6A3DRD4HTR7
SCHEMBL3959928 0.74 DRD4 (0.39) SLC6A4DRD4HTR7DRD2DRD3
SCHEMBL3959934 0.74 DRD4 (0.39) SLC6A4DRD4HTR7DRD2DRD3
Oxalic Acid SCHEMBL3966802 0.74 KDM4E (0.37) SLC6A2SLC6A4SLC6A3DRD4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544685-B2 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2009-06-09 US disclosed
CN-101243075-A Novel 2,3-dihydroindole compounds LUNDBECK & CO AS H (DK) 2008-08-13 CN disclosed
US-20070043058-A1 Novel 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043058-A1 Novel 2,3-dihydroindole compounds HTR2C, HTR2A, HTR5A SLC6A2 48/4885SLC6A4 28/4885SLC6A3 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.